Stefanie Fogel > DLA Piper LLP (US) > Boston, United States > Lawyer Profile
DLA Piper LLP (US) Offices
33 ARCH STREET
26TH FLOOR
BOSTON MA 02110-1447
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Stefanie Fogel
Work Department
Litigation, Arbitration and Investigations; Consumer Goods, Food and Retail; Energy and Natural Resources; Insurance; Antitrust and Competition; Food and Beverage; Retail and Fashion; Life Sciences Regulatory; Regulatory and Government Affairs
Position
Partner; Global Co-Chair, Consumer Goods, Food and Retail Sector; Co-Chair, FDA Regulatory Practice; Co-Chair, Food and Beverage Subsector
Lawyer Rankings
United States > Industry focus > Cannabis
DLA Piper LLP (US)
‘s cannabis practice provides clients with support on litigation and corporate transactions relating to the cannabis industry, as well as handling securities, capital markets and corporate governance matters. It is routinely instructed by private and publicly-traded companies working in the cannabis sector, start-ups, and venture capitals. Boston-based Stefanie Fogel heads up the group and has focused her practice on multinational food and consumer product regulation work, corporate compliance, and commercial and class action litigation. Maggie Craig, also in Boston, majors on regulatory compliance, product recalls, and consumer class action litigation. The Washington DC office was strengthened with the arrival of Perham Gorji from the Food and Drug Administration in July 2023.
Lawyer Rankings
Top Tier Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Tax > International tax
- Real estate > Land use/zoning
- Investment fund formation and management > Alternative/hedge funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- International trade > CFIUS
- Government > State attorneys general
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: transactional and regulatory
- Insurance > Advice to insurers
- Industry focus > Cannabis
- Dispute resolution > E-discovery
- Tax > Financial products
- Finance > Fintech
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: contentious
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Workplace and employment counseling
- Antitrust > Cartel
- Intellectual property > Copyright
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Real estate > Construction (including construction litigation)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: litigation
- Dispute resolution > General commercial disputes
- Government > Government contracts
- Dispute resolution > International arbitration
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Project finance
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- International trade > CFIUS
- Transport > Rail and road: litigation and regulation